88
Participants
Start Date
December 6, 2022
Primary Completion Date
October 8, 2023
Study Completion Date
October 23, 2023
TNX-1900
Patients will spray TNX-1900 once into each nostril.
Placebo Nasal Spray
Patients will spray placebo nasal spray once into each nostril.
Upstate Clinical Research Associates, LLC, Williamsville
Charlottesville Medical Research, LLC, Charlottesville
Peters Medical Research, High Point
Coastal Carolina Research Center, North Charleston
Clinical Neuroscience Solutions, Inc., Jacksonville
Clinical Neuroscience Solutions, Inc., Orlando
Segal Trials - Miami Lakes Medical Research Outpatient Site, Miami Lakes
Clinical Neuroscience Solutions, Inc., Memphis
DelRicht Research - Gulfport Memorial, Gulfport
Michigan Headache & Neurological Institute, Ann Arbor
Integrated Clinical Trial Services, Inc., West Des Moines
Clinical Investigation Specialists, Inc., Kenosha
Diamond Headache Clinic, Chicago
Clinvest Research, Springfield
Alliance for Multispecialty Research - Wichita West, Wichita
DelRicht Research - LCMC Health Urgent Care, New Orleans
DelRicht Research - Neighborhood Health, Prairieville
Preferred Research Partners, Inc., Little Rock
IPS Research Company, INC., Oklahoma City
DelRicht Research - Grassroots Healthcare, Tulsa
Austin Clinical Trial Partners, Austin
Alliance for Multispecialty Research - Las Vegas, Las Vegas
Synergy Research Centers - Synergy San Diego, Lemon Grove
Excell Research, Oceanside
Viking Clinical Research, LTD, Temecula
Boston Clinical Trials, Inc., Boston
Collaborators (1)
Premier
UNKNOWN
Tonix Pharmaceuticals, Inc.
INDUSTRY